http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016311136-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1aa877e508ad0f3a2ed38b5c6157f444
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2803
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-3955
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
filingDate 2016-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72e07d94d7dfcba5fbaed1906f98564b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eab1e4653052529a5d661b23a5b8c668
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d032ee40b312173c64bd5ac987986c0c
publicationDate 2022-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AU-2016311136-B2
titleOfInvention Combinations and uses thereof
abstract The present disclosure describes a pharmaceutical combination of an anti-CD19 antibody and a phosphoinositide 3-kinase inhibitor for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia and/or acute lymphoblastic leukemia.
priorityDate 2015-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421012904
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414583306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419548745
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466874851
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426228888
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12478
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378753
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID152743518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123935
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135565596
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID50905713
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419592782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16738692

Total number of triples: 43.